Navigation Links
Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
Date:4/9/2008

Vaccines for the World" conference. A third phase I study in healthy adults in St. Louis, Missouri, USA was launched in December 2007 and focuses on the immunogenicity and safety of two AERAS-402/Crucell Ad35 boost doses administered at three to six month intervals after BCG priming in healthy adults.

"The world urgently needs a new TB vaccine, and although we are still in the early stages of clinical trials, the preliminary data of this second phase I study are promising," said Dr. Jerald C. Sadoff, President and CEO of Aeras. "Aeras is delighted to be working with the excellent researchers at Crucell and SATVI. We are grateful to the Bill & Melinda Gates Foundation, the Netherlands Ministry of Foreign Affairs, and our other donors for their financial support of this trial and our vaccine development efforts."

This trial was conducted in the Boland-Overberg region of Western Cape Province in South Africa, which has one of the world's highest TB burdens.

"SATVI is proud to be playing such an important role in the global effort to develop new vaccines to combat TB, which are needed in South Africa and worldwide," said Dr. Gregory Hussey, Director of SATVI and Principal Investigator for the trial. "By conducting this trial, we have advanced the development of a new TB vaccine, expanded scientific capacity, and built awareness of the need for new TB vaccines."

About Tuberculosis

Tuberculosis is the world's second deadliest infectious disease, with over 9 million new cases diagnosed in 2006. According to the World Health Organization (WHO), an estimated 1.7 million people died from TB in 2006. One third of the world's population has been infected with the TB bacillus and current treatment takes 6-9 months. The current TB vaccine Bacille Calmette-Guerin (BCG), developed over 85 years ago, reduces the risk of severe forms of TB in early childhood, but is not very effective in preventing pulmonary TB in adolescents and adults - t
'/>"/>

SOURCE Aeras Global TB Vaccine Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
2. Artists for a New South Africa Will be Shaking The Blues at Gala Benefit November 15, With Performances by Erykah Badu, Nikka Costa, Keb Mo, Taj Mahal Trio, The Roots, and Guest Stars at The Wiltern in Los Angeles
3. Grammy Winner Marc Cohn to Perform for African AIDS Organization at Carolina HopeFest
4. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
5. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
6. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
7. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
8. Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials
9. Tampax and Always Launch Protecting Futures Program Dedicated to Helping African Girls Stay in School
10. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline
11. Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 This report analyzes the worldwide markets for ... Product Segments: SPECT Systems (Includes SPECT and SPECT/CT systems), and ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Latin America ... are provided for the period 2013 through 2020. Also, a ...
(Date:9/16/2014)... 2014 This report analyzes the worldwide markets for ... Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives, and Others. The report ... Animals. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period 2013 ...
(Date:9/16/2014)... , Sept. 16, 2014  ROX Medical ... an international multi-center, prospective, randomized, controlled, blinded endpoint ... of arterial hypertension. The CONTROL-HTN trial, NCT01642498, evaluated the ... a fixed connection between a central artery and ... treatment of hypertension. The primary outcomes are reduction ...
Breaking Medicine Technology:Global Nuclear Medicine Imaging Equipment Industry 2Global Nuclear Medicine Imaging Equipment Industry 3Global Nuclear Medicine Imaging Equipment Industry 4Global Nuclear Medicine Imaging Equipment Industry 5Global Nuclear Medicine Imaging Equipment Industry 6Global Nuclear Medicine Imaging Equipment Industry 7Global Nuclear Medicine Imaging Equipment Industry 8Global Nuclear Medicine Imaging Equipment Industry 9Global Nuclear Medicine Imaging Equipment Industry 10Global Nuclear Medicine Imaging Equipment Industry 11Global Nuclear Medicine Imaging Equipment Industry 12Global Nuclear Medicine Imaging Equipment Industry 13Global Nuclear Medicine Imaging Equipment Industry 14Global Nuclear Medicine Imaging Equipment Industry 15Global Nuclear Medicine Imaging Equipment Industry 16Global Nuclear Medicine Imaging Equipment Industry 17Global Nuclear Medicine Imaging Equipment Industry 18Global Nuclear Medicine Imaging Equipment Industry 19Global Nuclear Medicine Imaging Equipment Industry 20Global Nuclear Medicine Imaging Equipment Industry 21Global Nuclear Medicine Imaging Equipment Industry 22Global Nuclear Medicine Imaging Equipment Industry 23Global Nuclear Medicine Imaging Equipment Industry 24Global Nuclear Medicine Imaging Equipment Industry 25Global Nuclear Medicine Imaging Equipment Industry 26Global Animal Medication Industry 2Global Animal Medication Industry 3Global Animal Medication Industry 4Global Animal Medication Industry 5Global Animal Medication Industry 6Global Animal Medication Industry 7Global Animal Medication Industry 8Global Animal Medication Industry 9Global Animal Medication Industry 10Global Animal Medication Industry 11
(Date:9/16/2014)... Pulmonary Hypertension Association Travels to San Diego for PHA ... and Families to Help Fight Rare Lung Disease , Who:, ... hypertension association that works to find ways to prevent and ... that affects the functioning of the heart and can lead ... 2.8 years. , What:, PHA On The Road ...
(Date:9/16/2014)... Doheny HealthDay Reporter TUESDAY, ... can routinely spot human papillomavirus (HPV), which is linked to ... "Our study shows that testing urine for HPV has good ... for HPV," said lead researcher Dr. Neha Pathak. She is ... Queen Mary University of London, England. The test could ...
(Date:9/16/2014)... Cliff Lake Dental Care is proud to announce ... dental hygienist to join Dr. Rauchwarter's team. The team at ... and knows she will bring many benefits to the office ... in River Falls, WI. She finished dental assisting school ... practiced dental assisting in the Twin Cities, Milwaukee, California and ...
(Date:9/16/2014)... 2014 Aspen Advisors, a U.S.-based healthcare ... recognized for its high morale and collaborative culture ... Small Firms to Work For 2014.” Consulting magazine ... than 10,000 consultants participating across all major industries, representing ... were conducted, and firms were ranked in six categories ...
(Date:9/16/2014)... Treatment with endocrine therapy and radiation therapy as ... of care for women with hormone-receptor positive (HR+) ... at Fox Chase Cancer Center, however, shows that ... populations with the disease. , The results, ... Society for Radiation Oncology,s 56th Annual Meeting on ...
Breaking Medicine News(10 mins):Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 3Health News:Urine Test for HPV Works Well, Analysis Finds 2Health News:Cliff Lake Dental Care Announces Newest Team Member 2Health News:Aspen Advisors Earns Recognition in Consulting Magazine’s "Best Small Firms to Work For" 2Health News:Aspen Advisors Earns Recognition in Consulting Magazine’s "Best Small Firms to Work For" 3Health News:Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? 2Health News:Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? 3
... HARBIN, China, Aug. 11 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, ... CSKI ), a,leading fully integrated pharmaceutical company ... today announced the launch of,its new corporate website under ... The new website features an expanded ...
... 11 An insidious illness is stealing the vitality of ... closely mirror those of other conditions, it is frequently misdiagnosed, ... know they could prevent the condition, known as systemic Candida, ... Now Kathleen Kalaf, founder and president of the non-profit ...
... localized disease, research shows , TUESDAY, Aug. 11 ... in advanced prostate cancer patients but doesn,t reduce the ... researchers say. , They reported on the long-term survival ... trials launched in 1994. The trials examined the effects ...
... ... a two year partnership with XtremeSportsID™. The NBCF edition of the interactive emergency identification ... fulfill the NBCF mission to save lives through early detection and awareness. , ... Lahaina, HI (PRWEB) August ...
... , BALTIMORE, Aug. 11 , , To ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090811/NY59748LOGO ) , , News Facts ... created an engaging, first-of-its-kind Web-based series called the L e ... journalist Carol Martin . The resource brings together medical doctors, nurses, psychologists, ...
... , RESEARCH TRIANGLE PARK, N.C., Aug. 11 ... today announced the completion of a $16.1 million Series E ... Alta Partners, Sanderling Ventures and Asset Management Company participated in ... Proceeds from the financing will primarily be used to expand ...
Cached Medicine News:Health News:China Sky One Medical, Inc. Launches New Corporate Website 2Health News:China Sky One Medical, Inc. Launches New Corporate Website 3Health News:Kathleen Kalaf's Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 2Health News:Kathleen Kalaf's Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 3Health News:Oral Drug Ups Survival in Advanced Prostate Cancer Cases 2Health News:National Breast Cancer Foundation, Inc to Partner with XtremeSportsID™ on Revolutionary Medical Identification Bracelet 2Health News:National Breast Cancer Foundation, Inc to Partner with XtremeSportsID™ on Revolutionary Medical Identification Bracelet 3Health News:Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain 2Health News:Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain 3Health News:Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain 4Health News:Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain 5Health News:Chimerix Raises $16.1 Million in Series E Financing 2
... Reticulocyte Stain is an aqueous ... use in manual methods of ... has a one year shelf ... and can be used in ...
... Liquichek ToRCH Plus IgM Controls ... problems in your ToRCH IgM ... your test results. Liquichek ToRCH ... perfect complement to Liquichek ToRCH ...
... Plus Control is a bilevel ... the performance of the most ... assays. A weak positive and ... to monitor the performance of ...
Liquichek Unassayed Chemistry Control (Human) is a comprehensive, stable, liquid product designed to monitor general and special chemistry tests....
Medicine Products: